These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 16818713)
1. Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair. Toulany M; Kasten-Pisula U; Brammer I; Wang S; Chen J; Dittmann K; Baumann M; Dikomey E; Rodemann HP Clin Cancer Res; 2006 Jul; 12(13):4119-26. PubMed ID: 16818713 [TBL] [Abstract][Full Text] [Related]
2. Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS. Toulany M; Dittmann K; Baumann M; Rodemann HP Radiother Oncol; 2005 Feb; 74(2):117-29. PubMed ID: 15734199 [TBL] [Abstract][Full Text] [Related]
3. K-RAS(V12) induces autocrine production of EGFR ligands and mediates radioresistance through EGFR-dependent Akt signaling and activation of DNA-PKcs. Minjgee M; Toulany M; Kehlbach R; Giehl K; Rodemann HP Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1506-14. PubMed ID: 21985943 [TBL] [Abstract][Full Text] [Related]
4. Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair. Toulany M; Kehlbach R; Florczak U; Sak A; Wang S; Chen J; Lobrich M; Rodemann HP Mol Cancer Ther; 2008 Jul; 7(7):1772-81. PubMed ID: 18644989 [TBL] [Abstract][Full Text] [Related]
5. Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer. Toulany M; Iida M; Keinath S; Iyi FF; Mueck K; Fehrenbacher B; Mansour WY; Schaller M; Wheeler DL; Rodemann HP Oncotarget; 2016 Jul; 7(28):43746-43761. PubMed ID: 27248324 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous inhibition of EGFR and PI3K enhances radiosensitivity in human breast cancer. Li P; Zhang Q; Torossian A; Li ZB; Xu WC; Lu B; Fu S Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e391-7. PubMed ID: 22414288 [TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines. Kim IA; Bae SS; Fernandes A; Wu J; Muschel RJ; McKenna WG; Birnbaum MJ; Bernhard EJ Cancer Res; 2005 Sep; 65(17):7902-10. PubMed ID: 16140961 [TBL] [Abstract][Full Text] [Related]
8. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro. Toulany M; Dittmann K; Fehrenbacher B; Schaller M; Baumann M; Rodemann HP DNA Repair (Amst); 2008 Oct; 7(10):1746-56. PubMed ID: 18678286 [TBL] [Abstract][Full Text] [Related]
9. Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity. Toulany M; Baumann M; Rodemann HP Mol Cancer Res; 2007 Aug; 5(8):863-72. PubMed ID: 17699110 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibition of EGFR tyrosine kinase affects ILK-mediated cellular radiosensitization in vitro. Eke I; Sandfort V; Storch K; Baumann M; Röper B; Cordes N Int J Radiat Biol; 2007; 83(11-12):793-802. PubMed ID: 18058367 [TBL] [Abstract][Full Text] [Related]
11. Suppression of DNA-dependent protein kinase sensitize cells to radiation without affecting DSB repair. Gustafsson AS; Abramenkovs A; Stenerlöw B Mutat Res; 2014 Nov; 769():1-10. PubMed ID: 25771720 [TBL] [Abstract][Full Text] [Related]
12. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Gupta AK; McKenna WG; Weber CN; Feldman MD; Goldsmith JD; Mick R; Machtay M; Rosenthal DI; Bakanauskas VJ; Cerniglia GJ; Bernhard EJ; Weber RS; Muschel RJ Clin Cancer Res; 2002 Mar; 8(3):885-92. PubMed ID: 11895923 [TBL] [Abstract][Full Text] [Related]
13. Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation. Toulany M; Schickfluss TA; Eicheler W; Kehlbach R; Schittek B; Rodemann HP Breast Cancer Res; 2011 Mar; 13(2):R28. PubMed ID: 21392397 [TBL] [Abstract][Full Text] [Related]
14. Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway. Toulany M; Dittmann K; Krüger M; Baumann M; Rodemann HP Radiother Oncol; 2005 Aug; 76(2):143-50. PubMed ID: 16024124 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous Targeting of RSK and AKT Efficiently Inhibits YB-1-Mediated Repair of Ionizing Radiation-Induced DNA Double-Strand Breaks in Breast Cancer Cells. Lettau K; Zips D; Toulany M Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):567-580. PubMed ID: 32931865 [TBL] [Abstract][Full Text] [Related]
16. Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839). Friedmann B; Caplin M; Hartley JA; Hochhauser D Clin Cancer Res; 2004 Oct; 10(19):6476-86. PubMed ID: 15475435 [TBL] [Abstract][Full Text] [Related]
17. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival. Carón RW; Yacoub A; Li M; Zhu X; Mitchell C; Hong Y; Hawkins W; Sasazuki T; Shirasawa S; Kozikowski AP; Dennis PA; Hagan MP; Grant S; Dent P Mol Cancer Ther; 2005 Feb; 4(2):257-70. PubMed ID: 15713897 [TBL] [Abstract][Full Text] [Related]
18. 2-Methoxyestradiol-induced radiosensitization is independent of SOD but depends on inhibition of Akt and DNA-PKcs activities. Florczak U; Toulany M; Kehlbach R; Peter Rodemann H Radiother Oncol; 2009 Sep; 92(3):334-8. PubMed ID: 19589609 [TBL] [Abstract][Full Text] [Related]
19. Gefitinib radiosensitizes stem-like glioma cells: inhibition of epidermal growth factor receptor-Akt-DNA-PK signaling, accompanied by inhibition of DNA double-strand break repair. Kang KB; Zhu C; Wong YL; Gao Q; Ty A; Wong MC Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e43-52. PubMed ID: 22516386 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]